SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Molecular Partners AG Announces Publication of Results From a Phase I/II Clinical Trial of Its anti-VEGF DARPin MP0112 in Diabetic Macular Edema